Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
about
Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to BoneSignaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsThe diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives.Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.Novel therapeutic targets in myeloma bone disease.Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.The role of adiponectin in cancer: a review of current evidence.CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSAMSN1 is a tumor suppressor gene in multiple myeloma.Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.A prospective study of circulating adipokine levels and risk of multiple myeloma.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesA prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.Role of adiponectin and its receptors in cancerEvolving role of adiponectin in cancer-controversies and update.Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.Mechanisms of multiple myeloma bone disease.The role of bone marrow adipocytes in bone metastasis.Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.Contributions of the host microenvironment to cancer-induced bone disease.A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy.Trimming the fat: obesity and hematopoietic cell transplantation.Managing newly diagnosed follicular lymphoma: state of the art and future perspectives.The current status and future impact of targeted therapies in non-Hodgkin lymphoma.Bendamustine: role and evidence in lymphoma therapy, an overview.The skinny on obesity and plasma cell myeloma: a review of the literature.Adipocyte-derived players in hematologic tumors: useful novel targets?Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies.Molecular mechanisms, current management and next generation therapy in myeloma bone disease.Adipose, Bone, and Myeloma: Contributions from the Microenvironment.Adiponectin inhibits murine pancreatic cancer growth.PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells.Emerging treatment approaches for myeloma-related bone disease.MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.Connecting Bone and Fat: The Potential Role for Sclerostin.Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.
P2860
Q26740710-BC70C9D0-917E-4A44-B6FB-D99BC3D881B1Q26744596-74FFF57E-34D4-4E96-91A5-7B21DBA61905Q30984546-A591A17D-5899-4B18-A9BE-8BE3808DBEFDQ33558170-60E601B2-151E-4F55-A70A-22415FBD72B9Q34025065-2822AAA8-77FD-48BF-A41B-6F4DC1126AE2Q34052872-42BDF84E-4C30-47D8-B5FA-F57BFCF150A8Q34271986-EC947653-8A08-46C6-918A-7114ACB3547CQ34292995-0BCD18B4-F77A-430A-B44C-9FD7BF139951Q34347229-49FDE101-EFD8-408E-A426-8427E615E49FQ35644558-302EA8B1-E233-4C59-A695-9F7B081DB3B6Q35834665-95E7C9FE-D259-4E5E-AFFB-4B4E65F9D6B8Q36126937-A5A6F95C-C9A2-4652-9B72-9FA8395F0317Q36425446-FEFC586C-17DB-42FA-A440-4CC781FA6EB6Q36447553-55DA7DAF-AE92-4E87-9F80-2EAF339540CEQ36535684-1DF8F69F-0A20-4D7A-A561-B4B96B6FDE40Q36814438-F3080F1C-79C1-4C1A-9B30-760CC103AB26Q36849638-347AC05D-94BD-4D5D-B0B0-73B58200368BQ36930076-97D59B39-8BA5-4F8A-8924-132DF0B5771CQ37056408-4F6F0970-1748-468E-8A33-8D7E08856103Q37337511-0D0712D9-53A6-4A71-985E-F2AC06B162B9Q37527743-3626FAD6-FEB2-4F32-80A4-4A89058D3911Q37663962-0782981F-52BC-468F-B194-E2DAC6066E18Q37671439-A39B420F-5464-4346-B5A6-28F4FC1C2C6EQ37699183-45DD9A36-36B2-422D-A438-06BA48310BCDQ38056012-AEC7C760-A914-4558-8F53-5AAE997A0601Q38088002-18232FDC-BA26-4A50-AE9B-8CB0594EDEF1Q38095123-451531BE-03D8-4805-9529-408C2B0B2E6FQ38158084-345C7AB2-C34B-44EE-9F50-11C42EFB1634Q38211267-6A54877C-AE58-4467-A638-3CF8F8F7ED2EQ38259527-572501BF-B548-421A-A538-1B19357DA78EQ38521988-BE5C282B-0E26-4E46-BBD2-8C7F9807198FQ38749233-E6D2B9EF-60E3-48F0-89A6-2F7ECAD29E19Q38876521-57CF5B31-A866-4A94-875F-2D96BE0870B2Q38997907-F8FF8A5C-B2CB-4A93-A45D-FB08AE9A6EEEQ39013884-6572F841-E589-41B6-A613-76BC9B12F630Q39090721-42589816-6CB4-4A4A-910E-5F4754D8331DQ39255792-617083D7-B83F-4651-80A0-17128FB08D40Q39350147-E618A8FF-C10A-4EBF-AEDB-FCFA85FE7F99Q39595554-A0EEF03F-F482-4847-BE43-142CB1E38D82Q40164554-ADFDB815-6163-4B93-A9C3-0FCAD6228DF7
P2860
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Host-derived adiponectin is tu ...... d the associated bone disease.
@ast
Host-derived adiponectin is tu ...... d the associated bone disease.
@en
type
label
Host-derived adiponectin is tu ...... d the associated bone disease.
@ast
Host-derived adiponectin is tu ...... d the associated bone disease.
@en
prefLabel
Host-derived adiponectin is tu ...... d the associated bone disease.
@ast
Host-derived adiponectin is tu ...... d the associated bone disease.
@en
P2093
P2860
P1433
P1476
Host-derived adiponectin is tu ...... d the associated bone disease.
@en
P2093
Claire M Edwards
Gregory R Mundy
James R Edwards
Jessica A Fowler
Matthew T Drake
Seint T Lwin
P2860
P304
P356
10.1182/BLOOD-2011-01-330407
P407
P577
2011-09-08T00:00:00Z